Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
REPL | Replimune Group, Inc. | Chief Business Officer | $2.88M | Sep 11, 2023 | ||
KYMR | Kymera Therapeutics, Inc. | Director | $0 | -$774K | -100% | Dec 2, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|